EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression

[1]  S. Hung,et al.  RBM4 Regulates Neuronal Differentiation of Mesenchymal Stem Cells by Modulating Alternative Splicing of Pyruvate Kinase M , 2016, Molecular and Cellular Biology.

[2]  R. Storb,et al.  RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML. , 2016, Cell stem cell.

[3]  C. Sette,et al.  Alternative splicing and cell survival: from tissue homeostasis to disease , 2016, Cell Death and Differentiation.

[4]  Abigail J. Deloria,et al.  Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer , 2016, Oncotarget.

[5]  Luc Girard,et al.  ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. , 2016, The Journal of clinical investigation.

[6]  M. Balda,et al.  Tight junctions: from simple barriers to multifunctional molecular gates , 2016, Nature Reviews Molecular Cell Biology.

[7]  J. Collins,et al.  RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming. , 2016, Cell reports.

[8]  R. Lothe,et al.  Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes , 2016, Oncogene.

[9]  D. Black,et al.  The neurogenetics of alternative splicing , 2016, Nature Reviews Neuroscience.

[10]  J. Valcárcel,et al.  Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks , 2016, Genome research.

[11]  B. Cieply,et al.  Multiphasic and Dynamic Changes in Alternative Splicing during Induction of Pluripotency Are Coordinated by Numerous RNA-Binding Proteins. , 2016, Cell reports.

[12]  Yi Xing,et al.  Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition , 2016, Molecular and Cellular Biology.

[13]  S. Alahari,et al.  Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications , 2016, Molecular Cancer.

[14]  Hong Wang,et al.  Rac1b enhances cell survival through activation of the JNK2/c-JUN/Cyclin-D1 and AKT2/MCL1 pathways , 2016, Oncotarget.

[15]  S. Tavazoie,et al.  Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts , 2016, Genes & development.

[16]  M. Moyer,et al.  Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells. , 2015, Cancer letters.

[17]  Chaya Kalcheim,et al.  Epithelial–Mesenchymal Transitions during Neural Crest and Somite Development , 2015, Journal of clinical medicine.

[18]  U. Schmitz,et al.  A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages. , 2015, Blood.

[19]  Richard A. Moore,et al.  Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal , 2015, Proceedings of the National Academy of Sciences.

[20]  Stephen T. C. Wong,et al.  EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.

[21]  V. LeBleu,et al.  EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.

[22]  R. Weinberg,et al.  Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. , 2015, Trends in cell biology.

[23]  B. Blencowe,et al.  The alternative splicing factor Nova2 regulates vascular development and lumen formation , 2015, Nature Communications.

[24]  A. Ridley,et al.  Rho GTPase signalling in cell migration , 2015, Current opinion in cell biology.

[25]  Shuying Sun,et al.  SRSF1-Regulated Alternative Splicing in Breast Cancer. , 2015, Molecular cell.

[26]  M. Wood,et al.  An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies. , 2015, Current opinion in pharmacology.

[27]  Claude C. Warzecha,et al.  The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development , 2015, eLife.

[28]  M. Parsons,et al.  Cadherin Switch during EMT in Neural Crest Cells Leads to Contact Inhibition of Locomotion via Repolarization of Forces , 2015, Developmental cell.

[29]  C. Ghigna,et al.  SAM68: Signal Transduction and RNA Metabolism in Human Cancer , 2015, BioMed research international.

[30]  E. Pilozzi,et al.  Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells , 2015, Oncogene.

[31]  D. Rio,et al.  Mechanisms and Regulation of Alternative Pre-mRNA Splicing. , 2015, Annual review of biochemistry.

[32]  A. del Sol,et al.  Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival , 2015, PloS one.

[33]  Eshel Ben-Jacob,et al.  Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..

[34]  S. Weissman,et al.  Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming , 2015, Stem cell reports.

[35]  Hong Wu,et al.  Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. , 2015, Cancer research.

[36]  B. Blencowe,et al.  Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming , 2015, Genes & development.

[37]  Amanda E. Jones,et al.  Snail2/Slug cooperates with Polycomb repressive complex 2 (PRC2) to regulate neural crest development , 2015, Development.

[38]  Russ P Carstens,et al.  Functional roles of alternative splicing factors in human disease , 2015, Wiley interdisciplinary reviews. RNA.

[39]  N. Webster,et al.  Deletion of serine/arginine‐rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice , 2015, Hepatology.

[40]  L. weiswald,et al.  Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.

[41]  Sigrid A. Langhans,et al.  Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition , 2014, Front. Oncol..

[42]  Chaolin Zhang,et al.  Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. , 2014, Molecular cell.

[43]  P. Sharp,et al.  Building Robust Transcriptomes with Master Splicing Factors , 2014, Cell.

[44]  Randy J. Read,et al.  Transcriptional diversity during lineage commitment of human blood progenitors , 2014, Science.

[45]  Dan Chen,et al.  The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. , 2014, Cancer cell.

[46]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[47]  Jernej Ule,et al.  Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis. , 2014, Molecular cell.

[48]  K. Miyazawa,et al.  Epithelial Splicing Regulatory Proteins 1 (ESRP1) and 2 (ESRP2) Suppress Cancer Cell Motility via Different Mechanisms* , 2014, The Journal of Biological Chemistry.

[49]  M. Ares,et al.  Context-dependent control of alternative splicing by RNA-binding proteins , 2014, Nature Reviews Genetics.

[50]  C. Rabouille,et al.  Extracellular cleavage of E-cadherin promotes epithelial cell extrusion , 2014, Journal of Cell Science.

[51]  Nicolas Fossat,et al.  C to U RNA editing mediated by APOBEC1 requires RNA‐binding protein RBM47 , 2014, EMBO reports.

[52]  O. Silvennoinen,et al.  The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells , 2014, Oncogene.

[53]  Jignesh R. Parikh,et al.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. , 2014, Cell stem cell.

[54]  D. Scholtens,et al.  Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. , 2014, The Journal of clinical investigation.

[55]  A. Mele,et al.  Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer , 2014, eLife.

[56]  A. Groves,et al.  Setting appropriate boundaries: fate, patterning and competence at the neural plate border. , 2014, Developmental biology.

[57]  M. Salto‐Tellez,et al.  CD44v8-10 is a cancer-specific marker for gastric cancer stem cells. , 2014, Cancer research.

[58]  B. Zhou,et al.  Epigenetic regulation of EMT: the Snail story. , 2014, Current pharmaceutical design.

[59]  Kerry J. Davies.  The Complex Interaction of Matrix Metalloproteinases in the Migration of Cancer Cells through Breast Tissue Stroma , 2014, International journal of breast cancer.

[60]  M. Biffoni,et al.  CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. , 2014, Cell stem cell.

[61]  G. Christofori,et al.  The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion , 2014, Oncogene.

[62]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[63]  S. Ogawa,et al.  Splicing factor mutations and cancer , 2014, Wiley interdisciplinary reviews. RNA.

[64]  P. Chieffi,et al.  The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival , 2013, Nucleic acids research.

[65]  M. Bronner,et al.  Sip1 mediates an E-cadherin-to-N-cadherin switch during cranial neural crest EMT , 2013, The Journal of cell biology.

[66]  M. Moyer,et al.  Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells , 2013, RNA.

[67]  N. Copeland,et al.  Scrib is required for epithelial cell identity and prevents epithelial to mesenchymal transition in the mouse. , 2013, Developmental biology.

[68]  I. Herr,et al.  Triptolide reverses hypoxia-induced epithelial–mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation , 2013, International journal of cancer.

[69]  S. Yamanaka,et al.  Global splicing pattern reversion during somatic cell reprogramming. , 2013, Cell reports.

[70]  C. Ghigna,et al.  Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy , 2013, International journal of cell biology.

[71]  M. Korc,et al.  Epithelial Splicing Regulatory Protein 1 is a Favorable Prognostic Factor in Pancreatic Cancer that Attenuates Pancreatic Metastases , 2013, Oncogene.

[72]  J. Tazi,et al.  MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation , 2013, Nature Communications.

[73]  Pierre-Étienne Jacques,et al.  SON connects the splicing-regulatory network with pluripotency in human embryonic stem cells , 2013, Nature Cell Biology.

[74]  Carl-Philipp Heisenberg,et al.  Three Functions of Cadherins in Cell Adhesion , 2013, Current Biology.

[75]  C. Ghigna,et al.  HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition , 2013, Nucleic acids research.

[76]  Eric T. Wang,et al.  MBNL proteins repress ES-cell-specific alternative splicing and reprogramming , 2013, Nature.

[77]  Angélica Figueroa,et al.  Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition , 2013, Cellular and Molecular Life Sciences.

[78]  Prakash Kulkarni,et al.  Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing. , 2013, Cancer research.

[79]  Richard J. Jones,et al.  Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations , 2013, Oncotarget.

[80]  Lily Shiue,et al.  Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. , 2013, RNA.

[81]  Gene W. Yeo,et al.  Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. , 2013, Molecular cell.

[82]  Davalyn R. Powell,et al.  Riding the crest of the wave: parallels between the neural crest and cancer in epithelial-to-mesenchymal transition and migration , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

[83]  Andrés J. García,et al.  p120-catenin and β-catenin differentially regulate cadherin adhesive function , 2013, Molecular biology of the cell.

[84]  Benjamin J. Blencowe,et al.  Dynamic Integration of Splicing within Gene Regulatory Pathways , 2013, Cell.

[85]  Jessica M. Rusert,et al.  A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. , 2013, Cell stem cell.

[86]  Jun Yao,et al.  Tumor-Specific Isoform Switch of the Fibroblast Growth Factor Receptor 2 Underlies the Mesenchymal and Malignant Phenotypes of Clear Cell Renal Cell Carcinomas , 2013, Clinical Cancer Research.

[87]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[88]  Jiuhong Kang,et al.  Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma , 2013, Molecular Biology Reports.

[89]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[90]  T. Hagemann,et al.  The tumor microenvironment at a glance , 2012, Journal of Cell Science.

[91]  F. Rousset,et al.  RBFOX2 Is an Important Regulator of Mesenchymal Tissue-Specific Splicing in both Normal and Cancer Tissues , 2012, Molecular and Cellular Biology.

[92]  R. Carstens,et al.  Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors , 2012, Proceedings of the National Academy of Sciences.

[93]  E. Brambilla,et al.  Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma , 2012, PloS one.

[94]  Claude C. Warzecha,et al.  Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). , 2012, Seminars in cancer biology.

[95]  Jean Paul Thiery,et al.  Early events in cell adhesion and polarity during epithelial-mesenchymal transition , 2012, Journal of Cell Science.

[96]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions: insights from development , 2012, Development.

[97]  R. Weinberg,et al.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.

[98]  E. Gottlieb,et al.  Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer. , 2012, Trends in biochemical sciences.

[99]  Li Li,et al.  Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion , 2012, Archives of Gynecology and Obstetrics.

[100]  Masato Yano,et al.  Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. , 2012, Genes & development.

[101]  D. Radisky,et al.  Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression , 2012, Science Translational Medicine.

[102]  J. Visvader,et al.  Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.

[103]  Z. Q. Lim,et al.  Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention. , 2012, Genes & development.

[104]  Chi Wang,et al.  Interaction with Suv39H1 is Critical for Snail-mediated E-cadherin Repression in Breast Cancer , 2012, Oncogene.

[105]  R. Gomis,et al.  Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. , 2012, The Journal of clinical investigation.

[106]  C. Scuoppo,et al.  Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells , 2012, PloS one.

[107]  Jun Yao,et al.  G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. , 2012, The Journal of clinical investigation.

[108]  A. Krainer,et al.  Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. , 2012, Cell reports.

[109]  C. Ghigna,et al.  Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT) , 2012, Cellular and Molecular Life Sciences.

[110]  X. Bian,et al.  EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin , 2012, Oncogene.

[111]  D. Radisky,et al.  Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. , 2012, Cold Spring Harbor perspectives in biology.

[112]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[113]  A. Krainer,et al.  RNA therapeutics: beyond RNA interference and antisense oligonucleotides , 2012, Nature Reviews Drug Discovery.

[114]  A. Masuda,et al.  CUGBP1 and MBNL1 preferentially bind to 3′ UTRs and facilitate mRNA decay , 2012, Scientific Reports.

[115]  A. Krainer,et al.  THE SPLICING FACTOR SRSF1 REGULATES APOPTOSIS AND PROLIFERATION TO PROMOTE MAMMARY EPITHELIAL CELL TRANSFORMATION , 2011, Nature Structural &Molecular Biology.

[116]  N. Matsuura,et al.  Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. , 2011, The Annals of thoracic surgery.

[117]  K. Miyazono,et al.  TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP , 2011, Oncogene.

[118]  D. Planchard,et al.  Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.

[119]  Y. Toiyama,et al.  Radiation induces epithelial-mesenchymal transition in colorectal cancer cells. , 2011, Oncology reports.

[120]  D. Levasseur,et al.  Alternative Splicing Produces Nanog Protein Variants with Different Capacities for Self-renewal and Pluripotency in Embryonic Stem Cells* , 2011, The Journal of Biological Chemistry.

[121]  Auinash Kalsotra,et al.  Functional consequences of developmentally regulated alternative splicing , 2011, Nature Reviews Genetics.

[122]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[123]  Jeffrey L. Wrana,et al.  An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming , 2011, Cell.

[124]  M. Ringnér,et al.  CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers , 2011, BMC Cancer.

[125]  N. Jordan,et al.  Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer , 2011, Cell cycle.

[126]  C. Sette,et al.  The RNA-binding protein Sam68 is a multifunctional player in human cancer. , 2011, Endocrine-related cancer.

[127]  Nicholas C. Flytzanis,et al.  An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype , 2011, PLoS genetics.

[128]  Luigi Coppola,et al.  Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. , 2011, Cancer research.

[129]  V. Vaira,et al.  Aberrant overexpression of the cell polarity module scribble in human cancer. , 2011, The American journal of pathology.

[130]  Juergen A. Knoblich,et al.  Genome-Wide Analysis of Self-Renewal in Drosophila Neural Stem Cells by Transgenic RNAi , 2011, Cell stem cell.

[131]  B. Baum,et al.  Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling , 2011, The Journal of cell biology.

[132]  Chonghui Cheng,et al.  CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. , 2011, The Journal of clinical investigation.

[133]  A. Francis Stewart,et al.  PTBP1 Is Required for Embryonic Development before Gastrulation , 2011, PloS one.

[134]  T. Shibata,et al.  TGF-β regulates isoform switching of FGF receptors and epithelial–mesenchymal transition , 2011, The EMBO journal.

[135]  H. Allgayer,et al.  MicroRNAs-10a and -10b Contribute to Retinoic Acid-induced Differentiation of Neuroblastoma Cells and Target the Alternative Splicing Regulatory Factor SFRS1 (SF2/ASF)* , 2010, The Journal of Biological Chemistry.

[136]  J. Manley,et al.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. , 2010, Genes & development.

[137]  I. Fabregat,et al.  Snail1 suppresses TGF-β-induced apoptosis and is sufficient to trigger EMT in hepatocytes , 2010, Journal of Cell Science.

[138]  Yi Xing,et al.  An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition , 2010, The EMBO journal.

[139]  C. Ghigna,et al.  Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene , 2010, The Journal of cell biology.

[140]  D. Peeper,et al.  Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths , 2010, Aging.

[141]  J. Mulshine,et al.  hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. , 2010, Cancer research.

[142]  Xin Hu,et al.  Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition , 2010, Oncogene.

[143]  T. Keck,et al.  ZEB1 in Pancreatic Cancer , 2010, Cancers.

[144]  Kakajan Komurov,et al.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.

[145]  Eric T. Wang,et al.  Global regulation of alternative splicing during myogenic differentiation , 2010, Nucleic acids research.

[146]  Jialiang Liang,et al.  A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. , 2010, Cell stem cell.

[147]  C. Ghigna,et al.  Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: Therapeutic potential of bifunctional oligonucleotides and indole derivatives , 2010, RNA biology.

[148]  U. Tepass,et al.  Adherens junctions: from molecules to morphogenesis , 2010, Nature Reviews Molecular Cell Biology.

[149]  M. Herlyn,et al.  Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. , 2010, Cancer research.

[150]  Catalin C. Barbacioru,et al.  Tracing the Derivation of Embryonic Stem Cells from the Inner Cell Mass by Single-Cell RNA-Seq Analysis , 2010, Cell stem cell.

[151]  D. Radisky,et al.  Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[152]  D. Radisky,et al.  The 19-Amino Acid Insertion in the Tumor-associated Splice Isoform Rac1b Confers Specific Binding to p120 Catenin* , 2010, The Journal of Biological Chemistry.

[153]  M. Ikura,et al.  Dynamic and Static Interactions between p120 Catenin and E-Cadherin Regulate the Stability of Cell-Cell Adhesion , 2010, Cell.

[154]  S. Li,et al.  Numb: A new player in EMT. , 2010, Cell adhesion & migration.

[155]  M. Gerstein,et al.  Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing , 2010, Proceedings of the National Academy of Sciences.

[156]  M. Assanah,et al.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.

[157]  R. Breathnach,et al.  Combined Use of MS2 and PP7 Coat Fusions Shows that TIA-1 Dominates hnRNP A1 for K-SAM Exon Splicing Control , 2010, Journal of biomedicine & biotechnology.

[158]  T. Nilsen,et al.  Expansion of the eukaryotic proteome by alternative splicing , 2010, Nature.

[159]  A. Hecht,et al.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/β-catenin targets , 2009, Nucleic acids research.

[160]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[161]  N. Yoshida,et al.  Polypyrimidine tract‐binding protein is essential for early mouse development and embryonic stem cell proliferation , 2009, The FEBS journal.

[162]  Claude C. Warzecha,et al.  The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events , 2009, RNA biology.

[163]  A. Ghanate,et al.  Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53‐Mediated Apoptosis and Acquiring a Stem‐Like Phenotype in Ovarian Cancer Cells , 2009, Stem cells.

[164]  R. Simpson,et al.  Towards understanding epithelial-mesenchymal transition: a proteomics perspective. , 2009, Biochimica et biophysica acta.

[165]  Jeffrey M. Rosen,et al.  Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features , 2009, Proceedings of the National Academy of Sciences.

[166]  S. Li,et al.  Numb regulates cell–cell adhesion and polarity in response to tyrosine kinase signalling , 2009, The EMBO journal.

[167]  W. Nelson,et al.  Remodeling epithelial cell organization: transitions between front-rear and apical-basal polarity. , 2009, Cold Spring Harbor perspectives in biology.

[168]  T. Möller,et al.  Epithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenoviruses. , 2009, Cancer research.

[169]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[170]  C. Klein,et al.  Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.

[171]  Claude C. Warzecha,et al.  ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. , 2009, Molecular cell.

[172]  I. Weissman,et al.  Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation , 2009, Proceedings of the National Academy of Sciences.

[173]  Gene W. Yeo,et al.  An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells , 2009, Nature Structural &Molecular Biology.

[174]  P. Andrews,et al.  OCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells , 2008, Stem cells.

[175]  F. Portillo,et al.  Transcriptional regulation of cell polarity in EMT and cancer , 2008, Oncogene.

[176]  K. Mostov,et al.  From cells to organs: building polarized tissue , 2008, Nature Reviews Molecular Cell Biology.

[177]  Guojun Sheng,et al.  Epithelial to mesenchymal transition during gastrulation: An embryological view , 2008, Development, growth & differentiation.

[178]  Harold Varmus,et al.  Seeding and Propagation of Untransformed Mouse Mammary Cells in the Lung , 2008, Science.

[179]  L. Maquat,et al.  The multiple lives of NMD factors: balancing roles in gene and genome regulation , 2008, Nature Reviews Genetics.

[180]  Leping Li,et al.  Oct4/Sox2-Regulated miR-302 Targets Cyclin D1 in Human Embryonic Stem Cells , 2008, Molecular and Cellular Biology.

[181]  U. Philippar,et al.  Human Mena+11a Isoform Serves as a Marker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines , 2008, Clinical Cancer Research.

[182]  Ronit Vogt Sionov,et al.  Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. , 2008, Seminars in cancer biology.

[183]  R. Maestro,et al.  Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. , 2008, Cancer cell.

[184]  J. Cheville,et al.  A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease* , 2008, Journal of Biological Chemistry.

[185]  M. Garcia-Blanco,et al.  Receptor 2 Exon Iiic to Silence Fibroblast Growth Factor Hnrnp H and Hnrnp F Complex with Fox2 Supplemental Material , 2008 .

[186]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[187]  K. Helin,et al.  Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor , 2008, Molecular and Cellular Biology.

[188]  S. Ranade,et al.  Stem cell transcriptome profiling via massive-scale mRNA sequencing , 2008, Nature Methods.

[189]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[190]  A. Ben-Ze'ev,et al.  Epithelial-mesenchymal transition and the invasive potential of tumors. , 2008, Trends in molecular medicine.

[191]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[192]  Valeri Vasioukhin,et al.  Cell polarity and cancer – cell and tissue polarity as a non-canonical tumor suppressor , 2008, Journal of Cell Science.

[193]  C. Gottardi,et al.  Molecular components of the adherens junction. , 2008, Biochimica et biophysica acta.

[194]  R. Carstens,et al.  Heterogeneous Ribonucleoprotein M Is a Splicing Regulatory Protein That Can Enhance or Silence Splicing of Alternatively Spliced Exons* , 2007, Journal of Biological Chemistry.

[195]  J. Clements,et al.  Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.

[196]  Carien M Niessen,et al.  Tight junctions/adherens junctions: basic structure and function. , 2007, The Journal of investigative dermatology.

[197]  L. Hawthorn,et al.  Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells , 2007, Oncogene.

[198]  L. Miller,et al.  Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. , 2007, Cancer research.

[199]  A. Krainer,et al.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene , 2007, Nature Structural &Molecular Biology.

[200]  B. Blencowe,et al.  An RNA map predicting Nova-dependent splicing regulation , 2006, Nature.

[201]  B. Margolis,et al.  Tight junctions and cell polarity. , 2006, Annual review of cell and developmental biology.

[202]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[203]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[204]  C. Watson,et al.  Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. , 2006, Differentiation; research in biological diversity.

[205]  R. Cameron,et al.  Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. , 2006, Cancer research.

[206]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[207]  Michael R Green,et al.  Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. , 2005, Molecular cell.

[208]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[209]  G. Berx,et al.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells , 2005, Oncogene.

[210]  C. D’Souza-Schorey,et al.  Lysosomal Targeting of E-Cadherin: a Unique Mechanism for the Down-Regulation of Cell-Cell Adhesion during Epithelial to Mesenchymal Transitions , 2005, Molecular and Cellular Biology.

[211]  B. Frey,et al.  Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. , 2004, Molecular cell.

[212]  Z. Shao,et al.  Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma , 2004, Breast Cancer Research and Treatment.

[213]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[214]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[215]  M. Ozawa,et al.  The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation , 2004, Journal of Cell Science.

[216]  K. Pantel,et al.  Micrometastasis in breast cancer and other solid tumors. , 2004, Journal of biological regulators and homeostatic agents.

[217]  C. Erickson,et al.  MMP‐2 plays an essential role in producing epithelial‐mesenchymal transformations in the avian embryo , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[218]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[219]  H. Hanafusa,et al.  Abl Interactor 1 Promotes Tyrosine 296 Phosphorylation of Mammalian Enabled (Mena) by c-Abl Kinase* , 2003, Journal of Biological Chemistry.

[220]  Shoichiro Tsukita,et al.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail , 2003, Journal of Cell Science.

[221]  A. Danilkovitch-Miagkova.  Oncogenic signaling pathways activated by RON receptor tyrosine kinase. , 2003, Current cancer drug targets.

[222]  Dong Wang,et al.  Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential , 2003, Oncogene.

[223]  E. Carver,et al.  The Mouse Snail Gene Encodes a Key Regulator of the Epithelial-Mesenchymal Transition , 2001, Molecular and Cellular Biology.

[224]  R. Knuechel,et al.  Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[225]  C. Stern,et al.  Interactions between Wnt and Vg1 signalling pathways initiate primitive streak formation in the chick embryo. , 2001, Development.

[226]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[227]  Russ P. Carstens,et al.  An Intronic Splicing Silencer Causes Skipping of the IIIb Exon of Fibroblast Growth Factor Receptor 2 through Involvement of Polypyrimidine Tract Binding Protein , 2000, Molecular and Cellular Biology.

[228]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[229]  P. Jordan,et al.  Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors , 1999, Oncogene.

[230]  T. Inoue,et al.  Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. , 1999, International journal of molecular medicine.

[231]  J. Manley,et al.  Determinants of SR protein specificity. , 1999, Current opinion in cell biology.

[232]  M. Takeichi,et al.  Neural crest emigration from the neural tube depends on regulated cadherin expression. , 1998, Development.

[233]  J. Thiery,et al.  Xenopus cadherin-11 is expressed in different populations of migrating neural crest cells , 1998, Mechanisms of Development.

[234]  P. Comoglio,et al.  A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype , 1996, Molecular and cellular biology.

[235]  Tom Maniatis,et al.  Specific interactions between proteins implicated in splice site selection and regulated alternative splicing , 1993, Cell.

[236]  F. Rigo,et al.  Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects. , 2014, Advances in experimental medicine and biology.

[237]  Anke Busch,et al.  Evolution of SR protein and hnRNP splicing regulatory factors , 2012, Wiley interdisciplinary reviews. RNA.

[238]  Gene W. Yeo,et al.  Alternative splicing in stem cell self-renewal and diferentiation. , 2010, Advances in experimental medicine and biology.

[239]  F. Modugno,et al.  Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo , 2008, Clinical & Experimental Metastasis.

[240]  J. Frisén,et al.  Deconstructing stemness , 2005, The EMBO journal.

[241]  H. Miyake,et al.  Over expression of CD44V8-10 in human bladder cancer cells decreases their interaction with hyaluronic acid and potentiates their malignant progression. , 2004, The Journal of urology.

[242]  S. Zucker,et al.  Role of matrix metalloproteinases (MMPs) in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[243]  Christopher J. Lee,et al.  Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. , 2004, Nucleic acids research.

[244]  M. Mareel,et al.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. , 2001, Journal of cell science.